Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Heart Assoc ; 6(3)2017 Mar 14.
Article in English | MEDLINE | ID: mdl-28292746

ABSTRACT

BACKGROUND: Valvular interstitial cells (VICs) in the healthy aortic valve leaflet exhibit a quiescent phenotype, with <5% of VICs exhibiting an activated phenotype. Yet, in vitro culture of VICs on tissue culture polystyrene surfaces in standard growth medium results in rapid transformation to an activated phenotype in >90% of cells. The inability to preserve a healthy VIC phenotype during in vitro studies has hampered the elucidation of mechanisms involved in calcific aortic valve disease. This study describes the generation of quiescent populations of porcine VICs in 2-dimensional in vitro culture and their utility in studying valve pathobiology. METHODS AND RESULTS: Within 4 days of isolation from fresh porcine hearts, VICs cultured in standard growth conditions were predominantly myofibroblastic (activated VICs). This myofibroblastic phenotype was partially reversed within 4 days, and fully reversed within 9 days, following application of a combination of a fibroblast media formulation with culture on collagen coatings. Specifically, culture in this combination significantly reduced several markers of VIC activation, including proliferation, apoptosis, α-smooth muscle actin expression, and matrix production, relative to standard growth conditions. Moreover, VICs raised in a fibroblast media formulation with culture on collagen coatings exhibited dramatically increased sensitivity to treatment with transforming growth factor ß1, a known pathological stimulus, compared with VICs raised in either standard culture or medium with a fibroblast media formulation. CONCLUSIONS: The approach using a fibroblast media formulation with culture on collagen coatings generates quiescent VICs that more accurately mimic a healthy VIC population and thus has the potential to transform the study of the mechanisms of VIC activation and dysfunction involved in the early stages of calcific aortic valve disease.


Subject(s)
Aortic Valve Stenosis/genetics , Aortic Valve/metabolism , Aortic Valve/pathology , Calcinosis/genetics , Fibronectins/metabolism , Gene Expression Regulation , Muscle Proteins/genetics , Myofibroblasts/metabolism , RNA/genetics , Animals , Aortic Valve Stenosis/metabolism , Aortic Valve Stenosis/pathology , Apoptosis , Biomarkers/metabolism , Calcinosis/metabolism , Calcinosis/pathology , Cell Proliferation , Cells, Cultured , Cytokines/biosynthesis , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Immunohistochemistry , Male , Muscle Proteins/biosynthesis , Myofibroblasts/pathology , Reverse Transcriptase Polymerase Chain Reaction , Swine
SELECTION OF CITATIONS
SEARCH DETAIL